Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance.

Schaetti C, Hutubessy R, Ali SM, Pach A, Weiss MG, Chaignat CL, Khatib AM.

BMC Public Health. 2009 Apr 7;9:99. doi: 10.1186/1471-2458-9-99.

2.

Cholera vaccines for the developing world.

Lopez AL, Clemens JD, Deen J, Jodar L.

Hum Vaccin. 2008 Mar-Apr;4(2):165-9. Epub 2007 Oct 7. Review.

PMID:
18414029
3.

Oral vaccines for cholera control.

Chaturvedi S, Chaturvedi S.

Natl Med J India. 1997 Jan-Feb;10(1):17-8. Review.

PMID:
9069701
4.

Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review.

Mogasale V, Ramani E, Wee H, Kim JH.

PLoS Negl Trop Dis. 2016 Dec 8;10(12):e0005124. doi: 10.1371/journal.pntd.0005124. eCollection 2016 Dec. Review.

5.

[The current status of research on a cholera vaccine].

Fournier JM.

Bull Soc Pathol Exot. 1998;91(5 Pt 1-2):412-5. Review. French.

PMID:
10078377
6.

Yellow fever in Africa: public health impact and prospects for control in the 21st century.

Tomori O.

Biomedica. 2002 Jun;22(2):178-210. Review. English, Spanish.

PMID:
12152484
7.

Cholera vaccine: new preventive tool for endemic countries.

Verma R, Khanna P, Chawla S.

Hum Vaccin Immunother. 2012 May;8(5):682-4. doi: 10.4161/hv.19083. Epub 2012 May 1. Review.

PMID:
22634452
8.

Can oral cholera vaccination play a role in controlling a cholera outbreak?

Calain P, Chaine JP, Johnson E, Hawley ML, O'Leary MJ, Oshitani H, Chaignat CL.

Vaccine. 2004 Jun 23;22(19):2444-51. Review.

PMID:
15193408
9.

Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.

Patel MM, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9. doi: 10.1086/605059. Review.

PMID:
19817612
10.

Oral cholera vaccine--for whom, when, and why?

Topps MH.

Travel Med Infect Dis. 2006 Jan;4(1):38-42. Review.

PMID:
16887724
11.

Cholera: developments in prevention and cure.

van Loon FP.

Trop Geogr Med. 1993;45(6):269-73. Review.

PMID:
8116056
12.

Oral vaccines against cholera.

Shin S, Desai SN, Sah BK, Clemens JD.

Clin Infect Dis. 2011 Jun;52(11):1343-9. doi: 10.1093/cid/cir141. Epub 2011 Apr 14. Review.

PMID:
21498389
13.

Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.

Viret JF, Dietrich G, Favre D.

Vaccine. 2004 Jun 23;22(19):2457-69. Review.

PMID:
15193410
14.
15.

An overview of cholera vaccines and their public health implications.

Desai SN, Clemens JD.

Curr Opin Pediatr. 2012 Feb;24(1):85-91. doi: 10.1097/MOP.0b013e32834eb625. Review.

PMID:
22157363
16.

Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme.

Kaljee LM, Pack R, Pach A, Nyamete A, Stanton BF.

J Health Popul Nutr. 2004 Sep;22(3):293-303. Review.

PMID:
15609782
17.

Cholera vaccine: developmental strategies and problems.

Bhadra RK, Dasgupta U, Das J.

Indian J Biochem Biophys. 1994 Dec;31(6):441-8. Review.

PMID:
7875711
18.

Developing primary health clinical teams for public oral health services in Tasmania.

Cane RJ, Butler DR.

Aust Dent J. 2004 Dec;49(4):162-70. Review.

19.

Recent developments in cholera.

Shears P.

Curr Opin Infect Dis. 2001 Oct;14(5):553-8. Review.

PMID:
11964875
20.

When, how, and where can oral cholera vaccines be used to interrupt cholera outbreaks?

Clemens J, Holmgren J.

Curr Top Microbiol Immunol. 2014;379:231-58. doi: 10.1007/82_2013_353. Review.

PMID:
24402712

Supplemental Content

Support Center